These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11142623)

  • 1. The 18th International Papillomavirus Conference.
    Bonnez W
    Antivir Ther; 2000 Dec; 5(4):279-83. PubMed ID: 11142623
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccines discussed at papillomavirus conference.
    Larsen NS
    J Natl Cancer Inst; 1993 Nov; 85(21):1717-8. PubMed ID: 8105100
    [No Abstract]   [Full Text] [Related]  

  • 3. Human papillomavirus update. 15th annual International Papillomavirus Workshop, Gold Coast Australia, 6 December 1996.
    Matlashewski G
    Int J Cancer; 1997 May; 71(5):715-8. PubMed ID: 9180135
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of mature dendritic cells for anti-human papillomavirus peptide-based vaccination in transplant patients.
    Mariat C; Alamartine E; Sabido O; Berthoux F
    Transplant Proc; 2002 Nov; 34(7):2836-7. PubMed ID: 12431627
    [No Abstract]   [Full Text] [Related]  

  • 5. Human papillomavirus vaccines.
    Kahn JA; Bernstein DI
    Pediatr Infect Dis J; 2003 May; 22(5):443-5. PubMed ID: 12792387
    [No Abstract]   [Full Text] [Related]  

  • 6. Do we need antivirals for genital herpes simplex virus and human papillomavirus infection?
    Gross G
    Int J Antimicrob Agents; 1999 Jun; 12(1):1-3. PubMed ID: 10389641
    [No Abstract]   [Full Text] [Related]  

  • 7. HPV vaccine moves into late stage trials.
    Connett H
    Nat Med; 2001 Apr; 7(4):388. PubMed ID: 11283639
    [No Abstract]   [Full Text] [Related]  

  • 8. The end for genital human papillomavirus infections?
    Stanley M
    Lancet Oncol; 2005 May; 6(5):256-7. PubMed ID: 15863371
    [No Abstract]   [Full Text] [Related]  

  • 9. CDC releases 2002 guidelines for treating STDs: Part II. Human papillomavirus and hepatitis.
    Ressel GW;
    Am Fam Physician; 2002 Nov; 66(10):1996, 1999. PubMed ID: 12469970
    [No Abstract]   [Full Text] [Related]  

  • 10. Multistep carcinogenesis and genital papillomavirus infection. Implications for diagnosis and vaccines.
    Rangel LM; Ramírez M; Torroella M; Pedroza A; Ibarra V; Gariglio P
    Arch Med Res; 1994; 25(2):265-72. PubMed ID: 7919824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccinating women against premature death: summary of an International Workshop, Helsinki, Finland, 10.01.2000.
    Lehtinen M; Dillner J; Paavonen J
    Vaccine; 2001 Jan; 19(11-12):1347-52. PubMed ID: 11252250
    [No Abstract]   [Full Text] [Related]  

  • 12. [The beneficial effect of immunological and antiviral preparations in herpetic and papillomatosis infections].
    Topciu V; Sarău M; Mihăilescu R; Chercota G
    Bacteriol Virusol Parazitol Epidemiol; 1995; 40(3-4):257-60. PubMed ID: 8640014
    [No Abstract]   [Full Text] [Related]  

  • 13. Update on human papillomavirus vaccines for cervical cancer.
    Steller MA
    Curr Opin Investig Drugs; 2002 Jan; 3(1):37-47. PubMed ID: 12054070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDC recommends expensive vaccine for all girls aged 11-12.
    Tanne J
    BMJ; 2006 Jul; 333(7559):114. PubMed ID: 16840454
    [No Abstract]   [Full Text] [Related]  

  • 15. [Perspectives for the development of vaccines and immunotherapy against cervico-uterine cancer].
    Guzmán-Rojas L; Alcocer-González JM; Madrid-Marina V
    Salud Publica Mex; 1998; 40(1):38-46. PubMed ID: 9567657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccinating women against premature death. Proceedings of HPV vaccination workshop. January 10, 2000, Helsinki, Finland.
    J Clin Virol; 2000 Oct; 19(1-2):viii-ix, 1-133. PubMed ID: 11091155
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vaccination against human papillomavirus and against the cellular proliferation that it induces: facts and expectations].
    Giannouli C; Burny A; Hallez S
    J Gynecol Obstet Biol Reprod (Paris); 2000 May; 29(3):258-60. PubMed ID: 10804365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of preventive human papillomavirus vaccination.
    Lehtinen M; Paavonen J
    Int J STD AIDS; 2003 Dec; 14(12):787-92. PubMed ID: 14678583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous and mucous infections from human papilloma virus: new therapeutical approach.
    Verardi S; Zupy E; Marconi D; Romanini C; Casciani CU
    Clin Ter; 2000; 151(1 Suppl 1):35-52. PubMed ID: 10876965
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune response to human papillomaviruses and the prospects for human papillomavirus-specific immunisation.
    Tindle RW; Frazer IH
    Curr Top Microbiol Immunol; 1994; 186():217-53. PubMed ID: 8205843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.